首页 | 本学科首页   官方微博 | 高级检索  
     

Grave患者^131I治疗前后血清细胞间粘附分子—1水平的研究
引用本文:吴永刚,刘国锋,苏见知,何建军,潘佑民. Grave患者^131I治疗前后血清细胞间粘附分子—1水平的研究[J]. 中国现代医学杂志, 2001, 11(8): 33-34
作者姓名:吴永刚  刘国锋  苏见知  何建军  潘佑民
作者单位:中南大学湘雅二医院核医学科
摘    要:目的:探讨ICAM-1在Grave(GD)病发病中的作用。方法:应用ELISA法GD患者^131I治疗后不同时期血液ICAM的水平,并与正常对照组比较。结果:Grave病1周后,ICAM-1明显升高,并与FT3、FT4成正相关,6个月后ICAM-1显著低于治疗前组,但仍高于正常组。Grave眼病(GO)患者血清ICAM-1水平明显高于GD病人,而有甲亢患者ICAM-1明显高于无甲亢患者。结论:ICAM-1能动态反映GD的情况。在GO早期,宜采取激素补充治疗。

关 键 词:Grave病 细胞间粘附分子-1 放射性碘 治疗
修稿时间:2001-06-03

Serum Levels of ICAM-1 before and after 131I-Treatment of Grave's Diseases
Wu Yonggang,Liu Guofeng,Su Jianzhi,et al.. Serum Levels of ICAM-1 before and after 131I-Treatment of Grave's Diseases[J]. China Journal of Modern Medicine, 2001, 11(8): 33-34
Authors:Wu Yonggang  Liu Guofeng  Su Jianzhi  et al.
Affiliation:Wu Yonggang,Liu Guofeng,Su Jianzhi,et al. The Department of Nuclear Medicine,The Second Xiangya Hosptial,Central South University,Changsha 410011
Abstract:Objective:To assess the serum levels of ICAM-1 before and after 131 I-treatment of Grave's disease.Methods:We measured the serum levels of ICAM-1 of 0,1w,6M by ELISA method.Results:1. Significent increases were seen in free T 4 index(FT 41),free T 3 index(FT 31)within the first weeks,and TSH simultaneously decreased.2. The serum levels of ICAM is significant higher in GO than in non-GO and in hyperthrodism than in non-hyperthrodism.Conclusions:The elevated serum concentration of ICAM-1 in patient with GD probably reflects ongoing immune processes.
Keywords:ICAM-1  GD  131 I
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号